Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma

NCT05236036 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Astrocytoma
Glioblastoma
Glioblastoma, IDH-Wildtype
MGMT-Unmethylated Glioblastoma
Recurrent Glioblastoma

Interventions

DRUG: Mycophenolate Mofetil
OTHER: Quality-of-Life Assessment
RADIATION: Radiation Therapy
DRUG: Temozolomide

Sponsor

Northwestern University

Collaborators

[object Object]